Skip to main content
Year archive

Alphamab Oncology — 2023 filings

All 49 regulatory filings released by Alphamab Oncology (9966) in 2023, sourced directly from the official regulator.

49 Filings
2023 Period
2023 filings (49)
Filing Released Lang
EXTENSION OF WAIVER REGARDING THE QUALIFICATION AND EXPERIENCE OF A JOINT COMPANY SECRETARY
Regulatory Filings
2023-12-19 English
VOLUNTARY ANNOUNCEMENT - A PHASE I/II CLINICAL TRIAL OF JSKN033 FOR THE TREATMENT OF HER2-EXPRESSING ADVANCED OR METASTATIC SOLID TUMORS WAS APPROVED IN AUSTRALIA
Regulatory Filings
2023-12-08 English
VOLUNTARY ANNOUNCEMENT - PRESENTATION OF RESEARCH UPDATES ON KN026 AT THE SABCS 2023
Regulatory Filings
2023-12-07 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023
Regulatory Filings
2023-12-05 English
Next Day Disclosure Return
Regulatory Filings
2023-11-28 English
VOLUNTARY ANNOUNCEMENT - CLARIFICATION
Regulatory Filings
2023-11-24 English
INSIDE INFORMATION ANNOUNCEMENT - PRELIMINARY RESULTS OF A PHASE I CLINICAL TRIAL OF JSKN003 IN AUSTRALIA FOR THE TREATMENT OF HER2-EXPRESSING ADVANCED SOLID TUMORS
Regulatory Filings
2023-11-16 English
INSIDE INFORMATION ANNOUNCEMENT - UPDATES IN RELATION TO A PHASE III CLINICAL TRIAL OF KN046 FOR THE TREATMENT OF ADVANCED PDAC
Regulatory Filings
2023-11-14 English
VOLUNTARY ANNOUNCEMENT - UNUSUAL PRICE MOVEMENTS
Regulatory Filings
2023-11-14 English
VOLUNTARY ANNOUNCEMENT - KN026 WAS GRANTED BREAKTHROUGH THERAPY DESIGNATION BY THE NMPA
Regulatory Filings
2023-11-06 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2023
Regulatory Filings
2023-11-06 English
GRANT OF SHARE OPTIONS
Regulatory Filings
2023-10-24 English
VOLUNTARY ANNOUNCEMENT - RESEARCH RESULTS ON KN046 AND KN026 PRESENTED AT ESMO CONGRESS 2023
Regulatory Filings
2023-10-23 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2023
Regulatory Filings
2023-10-06 English
2023 INTERIM REPORT
Regulatory Filings
2023-09-28 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2023
Regulatory Filings
2023-09-06 English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2023
Regulatory Filings
2023-08-23 English
VOLUNTARY ANNOUNCEMENT - RESEARCH UPDATES ON KN046 AND KN026 FOR PRESENTATION AT ESMO CONGRESS 2023
Regulatory Filings
2023-08-10 English
DATE OF BOARD MEETING
Regulatory Filings
2023-08-08 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2023
Regulatory Filings
2023-08-03 English
VOLUNTARY ANNOUNCEMENT - FIRST PATIENT DOSED IN A PHASE III CLINICAL TRIAL OF KN026 IN COMBINATION WITH HB1801 FOR THE FIRST-LINE TREATMENT OF HER2-POSITIVE METASTATIC BC
Regulatory Filings
2023-07-28 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2023
Regulatory Filings
2023-07-06 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Regulatory Filings
2023-06-30 English
RESIGNATION OF A NON-EXECUTIVE DIRECTOR AND CHANGE IN COMPOSITION OF THE STRATEGY COMMITTEE
Regulatory Filings
2023-06-30 English
AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION
Regulatory Filings
2023-06-12 English
POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON JUNE 12, 2023
Regulatory Filings
2023-06-12 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2023
Regulatory Filings
2023-06-06 English
VOLUNTARY ANNOUNCEMENT - RESEARCH UPDATES ON KN026 IN COMBINATION WITH KN046 FOR PRESENTATION AT 2023 ASCO ANNUAL MEETING
Regulatory Filings
2023-06-06 English
Next Day Disclosure Return
Regulatory Filings
2023-05-23 English
INSIDE INFORMATION ANNOUNCEMENT - UPDATES IN RELATION TO A PHASE III CLINICAL TRIAL OF KN046 FOR THE TREATMENT OF ADVANCED SQ NSCLC
Regulatory Filings
2023-05-19 English
FORM OF PROXY FOR USE AT THE ANNUAL GENERAL MEETING TO BE HELD ON MONDAY, JUNE 12, 2023
Regulatory Filings
2023-05-09 English
NOTICE OF ANNUAL GENERAL MEETING
Regulatory Filings
2023-05-09 English
(1) PROPOSED GRANTING OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE NEW SHARES&#x3b; (2) PROPOSED RE-ELECTION OF RETIRING DIRECTORS&#x3b; (3) PROPOSED RE-APPOINTMENT OF AUDITOR&#x3b; (4) PROPO
Regulatory Filings
2023-05-09 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2023
Regulatory Filings
2023-05-05 English
2022 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT
Regulatory Filings
2023-04-27 English
2022 Annual Report
Regulatory Filings
2023-04-27 English
GRANT OF SHARE OPTIONS
Regulatory Filings
2023-04-25 English
CHANGE IN SHAREHOLDING STRUCTURE OF CONTROLLING SHAREHOLDERS
Regulatory Filings
2023-04-21 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2023
Regulatory Filings
2023-04-11 English
PROPOSED ADOPTION OF THE FIFTH AMENDED AND RESTATED ARTICLES OF ASSOCIATION
Regulatory Filings
2023-03-31 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2022
Regulatory Filings
2023-03-31 English
DATE OF BOARD MEETING
Regulatory Filings
2023-03-16 English
VOLUNTARY ANNOUNCEMENT - FIRST PATIENT DOSED IN A PHASE IA/IB CLINICAL TRIAL OF JSKN003 IN CHINA FOR THE TREATMENT OF HER2-EXPRESSING ADVANCED SOLID TUMORS
Regulatory Filings
2023-03-15 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2023
Regulatory Filings
2023-03-06 English
Next Day Disclosure Return
Regulatory Filings
2023-02-09 English
COMPLETION OF PLACING OF EXISTING SHARES AND TOP-UP SUBSCRIPTION OF NEW SHARES UNDER GENERAL MANDATE
Regulatory Filings
2023-02-09 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2023
Regulatory Filings
2023-02-06 English
PLACING OF EXISTING SHARES AND TOP-UP SUBSCRIPTION OF NEW SHARES UNDER GENERAL MANDATE
Regulatory Filings
2023-02-03 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2022
Regulatory Filings
2023-01-05 English